I have prostate cancer (PC). I was diagnosed in July, 2000 and treated in September, October, and November, 2000. I spent a great deal of time talking to doctors, researching books, researching the internet, and talking to cancer patients. I hope with this web page to pass on some of the information that I acquired to men who might become patients and those who are surviving PC patients.

I chose as my treatment ProstRcision. This treatment consists of radio active seeds implanted into the prostate followed by 7 weeks of conformal photon beam radiation. My treatment was performed at RCOG in Atlanta, GA. Their web address is: http://www.rcog.net

Why I Selected ProstRcision

I Selected ProstRcision as the treatment for my prostate cancer for several reasons:

1. It has a 10-year statistical study of cure rates computed by an outside independent agency. Its cure rates are the highest ever published.

2. Men with advanced cancer are not rejected for treatment in order to increase cure rates.

3. It is a synergistic dose-intensifying treatment since the iodine implant is done before the conformal radiation.

4. All prostate cancer patients are treated as though they have microscopic capsule penetration.

5. Doctors must be extensively trained; the requirement is at least 100 cases assisting other radiation oncologists before they are allowed to operate.

6. The treatment environment is one of compassion.

7. It has the only radiation oncologists in the country who seed the seminal vesicles.

8. The computerized ProstRcision database is the oldest and most extensive in the United States. This treatment has been used at RCOG since 1984.

9. I contacted and talked to 6 people who had been treated at RCOG. All talked very positive about the treatment.

Please note that I chose ProstRcision because I felt this was the best treatment for me. My recommendation for men with PC is do your homework and educate yourself. Then choose the best treatment suited for you. Remember the best treatment is the one that you choose.

I hope my web page will help you.

Getting Correct Information

Every year 190,000 men in the United States will be newly diagnosed with prostate cancer (PC) and 30,000 men will die from this disease. If these statistics are sobering, imagine the fright at actually hearing a diagnosis of PC. Often accompanying that fear comes a sense of helplessness, of being out -of-control because men are suddenly confronted with something totally unknown. When men listen to their doctor, look on the internet, read books or speak to friends, the situation only worsens as they learn that much of the information available about prostate cancer, especially about treatment, is conflicting and frequently inaccurate.

Doctors often disagree on which treatment they believe is the most effective for PC. Typically, if you go to a urologist, that doctor will recommend a radical prostatectomy. And, if you see a radiation oncologist, that doctor will recommend some type of radiotherapy. Because of this confusion, men with PC, plus their families, need to be part of the decision-making process for treatment of this disease. In fact, the choice of treatment is one of the most important decisions a man will make during his lifetime.

Prostate, Seminal Vesicle, and Cancerous Tumor

The cure of PC is dependent on three things:

Finding PC early with a prostate-specific antigen (PSA) test.

Selecting a treatment method with a proven high cure rate.

Selecting a doctor who knows how to cure prostate cancer.

Introduction to ProstRcision

This link provides a table of cure rates, evaluating your cancer,
curing prostate cancer and many more.

Partin Tables
Using a combination of prostate-specific antigen, clinical stage, and gleason score
these tables predict pathologic stage of localized prostate cancer.

PSA Test Reduces Prostate Cancer Deaths by 40%

When it comes to the documented 40 percent effectiveness of PSA testing in preventing death from prostate cancer, neither the American Cancer Society nor the discoverer of the PSA protein, Richard Ablin, are telling the public the complete story.

Chick Here to Read the full article.

'Landmark' cancer vaccine gets FDA approval

Click Here to Read the Full Article.

Information Links

Urine Biomarker Test More Accurate
in Detecting Prostate Cancer Than PSA

Cancer Update from John Hopkins Hospital

RC Cancer Centers

Centerwatch Clinical Trials Listing Service

Medline (National Library of Medicine)

NCI's Cancer Trials

A Guide to Fighting Prostate Cancer

Burzynski Clinic Houston Texas

Burzynski Clinic Patient Group Houston Texas

Facing Prostate Cancer, But How? New York Times

Phoenix5 Prostate Cancer Website Robert Young

Prostate Cancer Nomogram

Prostate Cancer USTOO Newsletters

A Revolutionary Approach to Prostate Cancer

Laparoscopic Radical Prostatectomy

Flax Oil & Cancer Information

Cancer Helper

ProstaScint Monoclonal Antibody Scan

Prostate Cancer Treatment Guide

New Cancer Treatment with HIFU Technology

The following men are Prostate Cancer Survivors.
Please feel free to call them about any questions that you might have.

Name	Treatment	Phone	Treatment Date	PSA 7/15/2004
Nelson Boudreaux	Seed Implant Plus Radiation	225-769-0152	9/1/2000	< 0.1
Harry Fitzgerald	Seed Implant plus Radiation	225-272-3927	9/1/2000	<0.1
Karl vonKnoblauch	Seed Implant plus Radiation	315-487-1344	9/1/2000	< 0.1
Sid Leatherwood	Seed Implant plus Radiation	901-379-1887	9/1/2000	< 0.1
Cecil Ranzino	Seed Implant plus Radiation	225-295-1143	8/1/2000	< 0.1
Marvin Bender	Surgery	225-201-9717	3/1/1997	4.77
Len Sedlin	Surgery	225-275-8707	4/1/1997	< 0.1
Lamy J. Chopin	Surgery	225-665-7379	11/1/1993	< 0.1
Dennis O'Hara	Surgery	845-473-9827	3/16/92	0.2
Fred L. Smith	Surgery	225-291-3652	11/1/1997	< 0.1
Dr. Louis J. Capozzoli	Iodine Seed Implant Alone	225-753-1467	9/16/02	< 0.1
Dr. Joseph Ricapito	Surgery	225-769-2762	6/1/1995	0.2
Robert Hudson	Surgery	225-261-3186	4/1/1998	< 0.1
Billy Lyon	Seed Implant plus Radiation	225-926-5489	2001	<0.1

Prostate Cancer Calculator Forecasting the Course of Disease

DENVER, CO, September 24, 2001.

This new web site can now forecast the medical future for men with prostate disease.
The site uses online calculators and a kind of
artificial intelligence, called artificial neural networks (ANNs), to
address various prostate cancer-related conditions. The calculators
"learn" and make prognoses by comparing each patient's characteristics
with a database of information from hundreds or thousands of other
patients.

Click Here for Calculator

Image-Guided Prostate Cryosurgery:
State of the Art

from Cancer Control: Journal of the Moffitt Cancer Center

Gary Onik, MD

Abstract and Introduction

Abstract

Background: Cryosurgery was first used to treat prostate cancer in the early 1970s but it was not until 1993, when the results from percutaneous ultrasound-guided cryosurgery were published, that the potential advantages of this treatment became apparent. Changes in equipment and techniques have improved the results of cryosurgery, in both tumor control and lower morbidity.
Methods: The author has reviewed data of his own and those of others concerning the changes in techniques employed and outcomes from prostate cryosurgery.
Results: Ultrasound-guided percutaneous transperineal placement of the cryoprobes allows monitoring of freezing in real time. Monitoring temperature at critical locations, separating the rectum and prostate by saline injection, and using argon gas rather than liquid nitrogen-based equipment have improved results and lowered complication rates. The technique produces outcomes similar to those obtained with brachytherapy and three-dimensional conformal radiation therapy.
Conclusions: Advantages of cryosurgery include the ability to re-treat patients without added morbidity and to treat salvage post radiation patients with acceptable results and morbidity. The recent demonstration that "nerve-sparing" cryosurgery is possible suggests that cryosurgery may be used more often.

Click Here to view the remainder of the article.

Government Funding for PC

Government funding for prostate cancer research historically has been less than for other serious diseases such as breast cancer and aids. The chart below illustrates the difference in allocation of Federal research dollars.

Allocated Research Dollars for Years 1999 thru 2001

	1999	2000	2001
Aids	2,530,900,000	2,867,700,000	3,036,200,000
Breast Cancer	474,700,000	523,800,000	553,000,000
Prostate Cancer	177,500,000	239,200,000	271,200,000

Prostate Cancer Statistics

Cancer Facts & Figures 2009 from American Cancer Society.

192,280 new cases will be diagnosed in the U. S. and 27,360 men will die of prostate cancer.

Prostate cancer is the 2nd leading cause of cancer death in men.

Symptoms:

Weak or interrupted urine flow.

Frequent urination or inability to urinate.

Difficulty starting or stopping urine flow.

Blood in the urine or burning during urination.

Frequent pain or stiffness in the lower back, pelvis or upper thighs.

Median age for developing disease:
71

Trends: Death Rates

Black Men: After 1993, lower by 2.3% per year on average.

White Men: After 1994, lower by 4.6% per year on average

Patient Advocates For Advanced Cancer Treatments. (PAACT)

This a newsletter for PC patients. It is free. Donations are accepted. It comes out 4 times per year.

PAACT was started 15 years ago by Lloyd Ney. Lloyd was not a doctor. He was a cancer patient that was given months to live after he was diagnosed with PC. He lived 15 years. When Lloyd started PAACT he was like a voice in the wilderness crying out to help his fellow man. The challenges were many and there was a great deal of opposition from much of the medical community to this brazen individual who dared to challenge the establishment and empower the patients with knowledge that up to then, was considered the domain of the physicians. Though his perseverance and dedication to the task of trying to understand the disease and help his fellow man, Lloyd established PAACT in 1984. His was the only newsletter published at that time by a patient for other PC patients that was made available to anyone.

The Address is:

Patient Advocates For Advanced Cancer Treatments, Inc.

PO Box 141695

Grand Rapids, MI 49514

Phone: (616) 453-1477

http://paactusa.org/

Good Books

"The Best Options for Diagnosing & Treating Prostate Cancer"
by James Lewis, Jr., Ph.D. Survivor and Author

"Man to Man"
by Michael Korda

Masculinity versus Castration by Santiago Vilas, Ph.D.

I have been reading prostate cancer material for the past 3 ½ years and the book “Masculinity versus Castration” by Santiago Vilas, Ph.D. is one of the best. Dr. Vilas has presented the medical history of prostate cancer from the beginning to the present time. . He covers everything a man should know about prostate cancer. Dr. Vilas points out that a patient should educate himself first then proceed to find the best treatment. Two very important things that should be considered before a treatment is chosen, what is the cure rate and what are the side effects. Every man 40 years old and above should read this book.

Nelson Boudreaux

Prostate Cancer is Curable by

Santiago Vilas, Ph.D.

http://www.prostatecanceriscurable.com/

Urinary Incontinence and Erectile Dysfunction

Prostate surgery can be a life-changing event-both emotinally and physically. And there may be significant issues to face on your road to long-term recovery. Two possible physical results of the surgery may be loss of bladder control and/or erectile dysfunction (ED). There are treatments available for both conditions. The following link takes you to one source of treatments.
http://www.visitAMS.com

PSA Test Reduces Prostate Cancer Deaths by 40% When it comes to the documented 40 percent effectiveness of PSA testing in preventing death from prostate cancer, neither the American Cancer Society nor the discoverer of the PSA protein, Richard Ablin, are telling the public the complete story.

'Landmark' cancer vaccine gets FDA approval

Abstract and Introduction

Abstract

PSA Test Reduces Prostate Cancer Deaths by 40%

When it comes to the documented 40 percent effectiveness of PSA testing in preventing death from prostate cancer, neither the American Cancer Society nor the discoverer of the PSA protein, Richard Ablin, are telling the public the complete story.